Old Web
English
Sign In
Acemap
>
authorDetail
>
Naokata Sumitomo
Naokata Sumitomo
Chugai Pharmaceutical Co.
Tocilizumab
Physical therapy
Macrophage activation syndrome
Medicine
Rash
2
Papers
133
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Tocilizumab in systemic juvenile idiopathic arthritis in a real-world clinical setting: results from 1 year of postmarketing surveillance follow-up of 417 patients in Japan
2016
Annals of the Rheumatic Diseases
Shumpei Yokota
Yasuhiko Itoh
Tomohiro Morio
Hideki Origasa
Naokata Sumitomo
Minako Tomobe
Kunihiko Tanaka
Seiji Minota
Show All
Source
Cite
Save
Citations (66)
Macrophage Activation Syndrome in Patients with Systemic Juvenile Idiopathic Arthritis under Treatment with Tocilizumab.
2015
The Journal of Rheumatology
Shumpei Yokota
Yasuhiko Itoh
Tomohiro Morio
Naokata Sumitomo
Kaori Daimaru
Seiji Minota
Show All
Source
Cite
Save
Citations (67)
1